ARRAY BIOPHARMA Stock Price
$5.86 
Change:
0.23 2.04% Volume:
95,418
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 5.88 | Todays Low: 5.63 | Open: 5.63 | Last Close: 5.66
52 Wk High: 6.55 | 52 Wk Low: 3 | Todays Pivot: 5.79 | Pre market open: 5.01
Sector: 
Online News For Array Biopharma
|
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO ... - MarketWatch (press release)
Wed, 15 May 2013 12:07BOULDER, Colo., May 15, 2013 /PRNewswire via COMTEX/ -- Array BioPharma Inc. (NASDAQ:ARRY) today announced presentations on its MEK inhibitors, MEK162 (licensed to Novartis) and selumetinib (licensed to AstraZeneca) at the 2013 American ...
|
|
Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference ... - Seeking Alpha
Tue, 21 May 2013 17:29As I've been saying for the recent past that's certainly going to be a very pivotal year for Array this year and I'm going to talk about some of the reasons why. Before I start I'm going to be making forward-looking statements that involve risks and I ...
|
|
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company? - Seeking Alpha
Sun, 12 May 2013 22:13Boulder, Colorado-based Array BioPharma Inc. (ARRY) is a $594M market cap biopharmaceutical company that discovers, develops and commercializes targeted small molecule drugs to treat cancers and inflammatory diseases. The company believes that ...
|
|
Array Biopharma, Inc. (ARRY) Misses Q3 EPS by 4c; to Commence MEK162 ... - StreetInsider.com (subscription)
Mon, 06 May 2013 20:15Also today, Array announced the planned start of its first company-led Phase 3 trial with MEK162 in low-grade serous ovarian cancer. This is the third MEK162 pivotal trial that is expected to initiate in 2013 and one of five pivotal trials Array ...
|
|
Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare ... - MarketWatch (press release)
Wed, 08 May 2013 12:02BOULDER, Colo., May 8, 2013 /PRNewswire via COMTEX/ -- Array BioPharma Inc. (NASDAQ:ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas and ...
|
|
Hot Stocks: SolarCity Corp (NASDAQ:SCTY), Array Biopharma Inc (NASDAQ ... - SBWire (press release)
Wed, 08 May 2013 13:46Array Biopharma Inc (NASDAQ:ARRY) shares fell 9.66% to $5.24. The company, on May 6, announced that it will initiate a global Phase 3 clinical trial in patients with recurrent low-grade serous ovarian cancer (LGSOC) during the summer of 2013. The study ...
|
ARRY Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Array Biopharma quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ARRY to choose from. Visit here to build your stock quote widget »
